{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cancer", "cancer treatment", "metabolism", "signaling pathways"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33580511", "DateCompleted": {"Year": "2021", "Month": "10", "Day": "19"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "19"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "02", "Day": "12"}], "Language": ["eng"], "ELocationID": ["10.1002/jcp.30276"], "Journal": {"ISSN": "1097-4652", "JournalIssue": {"Volume": "236", "Issue": "8", "PubDate": {"Year": "2021", "Month": "Aug"}}, "Title": "Journal of cellular physiology", "ISOAbbreviation": "J Cell Physiol"}, "ArticleTitle": "Signaling, metabolism, and cancer: An important relationship for therapeutic intervention.", "Pagination": {"StartPage": "5512", "EndPage": "5532", "MedlinePgn": "5512-5532"}, "Abstract": {"AbstractText": ["In cancerous cells, significant changes occur in the activity of signaling pathways affecting a wide range of cellular activities ranging from growth and proliferation to apoptosis, invasiveness, and metastasis. Extensive changes also happen with respect to the metabolism of a cancerous cell encompassing a wide range of functions that include: nutrient\u00a0acquisition, biosynthesis of macromolecules, and energy generation. These changes are important and some therapeutic approaches for treating cancers have focused on targeting the metabolism of cancerous cells. Oncogenes and tumor suppressor genes have a significant effect on the metabolism of cells. There appears to be a close interaction between metabolism and the signaling pathways in a cancerous cell, in which the interaction provides the metabolic needs of a cancerous cell for uncontrolled proliferation, resistance to apoptosis, and metastasis. In this review, we have reviewed the latest findings in this regard and briefly review the most recent research findings regarding targeting the metabolism of cancer cells as a therapeutic approach for treatment of cancer."], "CopyrightInformation": "\u00a9 2021 Wiley Periodicals LLC."}, "AuthorList": [{"Identifier": ["0000-0002-1826-2637"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Biochemistry and Laboratory Medicine, School of Medicine, Tabriz University of\u00a0Medical Sciences, Tabriz, Iran."}, {"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Vaghari-Tabari", "ForeName": "Mostafa", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Education, Brighton & Sussex Medical School,\u00a0Falmer, Brighton, Sussex, UK."}], "LastName": "Ferns", "ForeName": "Gordon A", "Initials": "GA"}, {"Identifier": ["0000-0003-1344-9344"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Biology Research Center (CMBRC), Health Research Institute, Babol University of Medical Sciences, Babol, Iran."}, {"Identifier": [], "Affiliation": "Department of Clinical Biochemistry, Babol University of Medical Sciences, Babol, Iran."}], "LastName": "Qujeq", "ForeName": "Durdi", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran."}], "LastName": "Andevari", "ForeName": "Ali Nosrati", "Initials": "AN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Sabahi", "ForeName": "Zahra", "Initials": "Z"}, {"Identifier": ["0000-0001-8465-3604"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Moein", "ForeName": "Soheila", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Cell Physiol", "NlmUniqueID": "0050222", "ISSNLinking": "0021-9541"}, "MeshHeadingList": [{"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Energy Metabolism"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pathology"], "DescriptorName": "Neoplasm Metastasis"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Signal Transduction"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abolghasemi, M., Yousefi, T., Maniati, M., & Qujeq, D. (2019). The interplay of Klotho with signaling pathway and microRNAs in cancers. Journal of Cellular Biochemistry, 120, 14306-14317."}, {"Citation": "Altman, B. J., Stine, Z. E., & Dang, C. V. (2016). From Krebs to clinic: Glutamine metabolism to cancer therapy. Nature Reviews Cancer, 16, 619-634."}, {"Citation": "Amable, G., Martinez-Leon, E., Picco, M. E., Di Siervi, N., Davio, C., Rozengurt, E., & Rey, O. (2019). Metformin inhibits beta-catenin phosphorylation on Ser-552 through an AMPK/PI3K/Akt pathway in colorectal cancer cells. The International Journal of Biochemistry & Cell Biology, 112, 88-94."}, {"Citation": "Amelio, I., Cutruzzola, F., Antonov, A., Agostini, M., & Melino, G. (2014). Serine and glycine metabolism in cancer. Trends in Biochemical Sciences, 39, 191-198."}, {"Citation": "Arruabarrena-Aristorena, A., Zabala-Letona, A., & Carracedo, A. (2018). Oil for the cancer engine: The cross-talk between oncogenic signaling and polyamine metabolism. Science Advances, 4, eaar2606."}, {"Citation": "Ashton, T. M., McKenna, W. G., Kunz-Schughart, L. A., & Higgins, G. S. (2018). Oxidative phosphorylation as an emerging target in cancer therapy. Clinical Cancer Research, 24, 2482-2490."}, {"Citation": "Bandyopadhyay, S., Pai, S. K., Watabe, M., Gross, S. C., Hirota, S., Hosobe, S., Tsukada, T., Miura, K., Saito, K., Markwell, S. J., Wang, Y., Huggenvik, J., Pauza, M. E., Iiizumi, M., & Watabe, K. (2005). FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis. Oncogene, 24, 5389-5395."}, {"Citation": "Banning, A., Deubel, S., Kluth, D., Zhou, Z., & Brigelius-Flohe, R. (2005). The GI-GPx gene is a target for Nrf2. Molecular and Cellular Biology, 25, 4914-4923."}, {"Citation": "Bao, Y., Ding, Z., Zhao, P., Li, J., Chen, P., Zheng, J., & Qian, Z. (2020). Autophagy inhibition potentiates the anti-EMT effects of alteronol through TGF-beta/Smad3 signaling in melanoma cells. Cell Death & Disease, 11, 223."}, {"Citation": "Bar-Peled, L., & Sabatini, D. M. (2014). Regulation of mTORC1 by amino acids. Trends in Cell Biology, 24, 400-406."}, {"Citation": "Baumann, M. U., Zamudio, S., & Illsley, N. P. (2007). Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1. American Journal of Physiology Cell Physiology, 293, C477-C485."}, {"Citation": "Beloribi-Djefaflia, S., Vasseur, S., & Guillaumond, F. (2016). Lipid metabolic reprogramming in cancer cells. Oncogenesis, 5, e189."}, {"Citation": "Bensaad, K., Favaro, E., Lewis, C. A., Peck, B., Lord, S., Collins, J. M., Pinnick, K. E., Wigfield, S., Buffa, F. M., Li, J. L., Zhang, Q., Wakelam, M. J. O., Karpe, F., Schulze, A., & Harris, A. L. (2014). Fatty acid uptake and lipid storage induced by HIF-1alpha contribute to cell growth and survival after hypoxia-reoxygenation. Cell Reports, 9, 349-365."}, {"Citation": "Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006). TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell, 126, 107-120."}, {"Citation": "Ben-Sahra, I., Howell, J. J., Asara, J. M., & Manning, B. D. (2013). Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science, 339, 1323-1328."}, {"Citation": "Ben-Sahra, I., Hoxhaj, G., Ricoult, S. J. H., Asara, J. M., & Manning, B. D. (2016). mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle. Science, 351, 728-733."}, {"Citation": "Bok, R., Lee, J., Sriram, R., Keshari, K., Sukumar, S., Daneshmandi, S., Korenchan, D. E., Flavell, R. R., Vigneron, D. B., Kurhanewicz, J., & Seth, P. (2019). The role of lactate metabolism in prostate cancer progression and metastases revealed by dual-agent hyperpolarized (13)C MRSI. Cancers, 11(2), 257."}, {"Citation": "Bollu, L. R., Katreddy, R. R., Blessing, A. M., Pham, N., Zheng, B., Wu, X., & Weihua, Z. (2015). Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation. Oncotarget, 6, 34992-35003."}, {"Citation": "Borahay, M. A., Vincent, K., Motamedi, M., Sbrana, E., Kilic, G. S., Al-Hendy, A., & Boehning, D. (2015). Novel effects of simvastatin on uterine fibroid tumors: In vitro and patient-derived xenograft mouse model study. American Journal of Obstetrics and Gynecology, 213(196), e191-e198."}, {"Citation": "Boysen, G., Jamshidi-Parsian, A., Davis, M. A., Siegel, E. R., Kore, R. A., Dings, R. P. M., & Griffin, R. J. (2018). Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice. International Journal of Radiation Biology, 1-23."}, {"Citation": "Calvert, A. E., Chalastanis, A., Wu, Y., Hurley, L. A., Kouri, F. M., Bi, Y., Kachman, M., May, J. L., Bartom, E., Hua, Y., Mishra, R. K., Schiltz, G. E., Dubrovskyi, O., Mazar, A. P., Peter, M. E., Zheng, H., James, C. D., Burant, C. F., Chandel, N. S., \u2026 Stegh, A. H. (2017). Cancer-associated IDH1 promotes growth and resistance to targeted therapies in the absence of mutation. Cell Reports, 19, 1858-1873."}, {"Citation": "Calvisi, D. F., Ladu, S., Conner, E. A., Seo, D., Hsieh, J. T., Factor, V. M., & Thorgeirsson, S. S. (2011). Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer. Journal of Hepatology, 54, 311-319."}, {"Citation": "Cao, D., Song, X., Che, L., Li, X., Pilo, M. G., Vidili, G., Porcu, A., Solinas, A., Cigliano, A., Pes, G. M., Ribback, S., Dombrowski, F., Chen, X., Li, L., & Calvisi, D. F. (2017). Both de novo synthesized and exogenous fatty acids support the growth of hepatocellular carcinoma cells. Liver International, 37, 80-89."}, {"Citation": "Cardoso, H. J., Vaz, C. V., Carvalho, T. M. A., Figueira, M. I., & Socorro, S. (2019). Tyrosine kinase inhibitor imatinib modulates the viability and apoptosis of castrate-resistant prostate cancer cells dependently on the glycolytic environment. Life Sciences, 218, 274-283."}, {"Citation": "Chang, C. L., Marra, G., Chauhan, D. P., Ha, H. T., Chang, D. K., Ricciardiello, L., Randolph, A., Carethers, J. M., & Boland, C. R. (2002). Oxidative stress inactivates the human DNA mismatch repair system. American Journal of Physiology: Cell Physiology, 283, C148-C154."}, {"Citation": "Chatterjee, S., Browning, E. A., Hong, N., DeBolt, K., Sorokina, E. M., Liu, W., Birnbaum, M. J., & Fisher, A. B. (2012). Membrane depolarization is the trigger for PI3K/Akt activation and leads to the generation of ROS. American Journal of Physiology: Heart and Circulatory Physiology, 302, H105-H114."}, {"Citation": "Cho, E. S., Cha, Y. H., Kim, H. S., Kim, N. H., & Yook, J. I. (2018). The pentose phosphate pathway as a potential target for cancer therapy. Biomolecules & therapeutics, 26, 29-38."}, {"Citation": "Choi, Y. K., & Park, K. G. (2018). Targeting glutamine metabolism for cancer treatment. Biomolecules & Therapeutics, 26, 19-28."}, {"Citation": "Comito, G., Iscaro, A., Bacci, M., Morandi, A., Ippolito, L., Parri, M., Montagnani, I., Raspollini, M. R., Serni, S., Simeoni, L., Giannoni, E., & Chiarugi, P. (2019). Lactate modulates CD4(\u2009+\u2009) T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis. Oncogene, 38, 3681-3695."}, {"Citation": "Cong, P. F., Qu, Y. C., Chen, J. P., Duan, L. L., Lin, C. J., Zhu, X. L., Li-Ling, J., & Zhang, M. X. (2015). Growth inhibition and apoptosis induction by alternol in pancreatic carcinoma cells. World Journal of Gastroenterology, 21, 4526-4535."}, {"Citation": "Croce, C. M. (2008). Oncogenes and cancer. The New England Journal of Medicine, 358, 502-511."}, {"Citation": "Csibi, A., Fendt, S. M., Li, C., Poulogiannis, G., Choo, A. Y., Chapski, D. J., Jeong, S. M., Dempsey, J. M., Parkhitko, A., Morrison, T., Henske, E. P., Haigis, M. C., Cantley, L. C., Stephanopoulos, G., Yu, J., & Blenis, J. (2013). The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4. Cell, 153, 840-854."}, {"Citation": "Csibi, A., Lee, G., Yoon, S. O., Tong, H., Ilter, D., Elia, I., Fendt, S. M., Roberts, T. M., & Blenis, J. (2014). The mTORC1/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation. Current Biology, 24, 2274-2280."}, {"Citation": "Cunningham, J. T., Moreno, M. V., Lodi, A., Ronen, S. M., & Ruggero, D. (2014). Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer. Cell, 157, 1088-1103."}, {"Citation": "Dai, H., Deng, H. B., Wang, Y. H., & Guo, J. J. (2018). Resveratrol inhibits the growth of gastric cancer via the Wnt/beta-catenin pathway. Oncology Letters, 16, 1579-1583."}, {"Citation": "Dang, C. V. (2010). Glutaminolysis: Supplying carbon or nitrogen or both for cancer cells? Cell Cycle, 9, 3884-3886."}, {"Citation": "Dang, C. V. (2012). MYC on the path to cancer. Cell, 149, 22-35."}, {"Citation": "Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997). Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91, 231-241."}, {"Citation": "de Ggonzalo-Calvo, D., Lopez-Vilaro, L., Nasarre, L., Perez-Olabarria, M., Vazquez, T., Escuin, D., Badimon, L., Barnadas, A., Lerma, E., & Llorente-Cortes, V. (2015). Intratumor cholesteryl ester accumulation is associated with human breast cancer proliferation and aggressive potential: A molecular and clinicopathological study. BMC Cancer, 15, 460."}, {"Citation": "Dejure, F. R., & Eilers, M. (2017). MYC and tumor metabolism: Chicken and egg. The EMBO Journal, 36, 3409-3420."}, {"Citation": "Deng, S., Yang, Y., Han, Y., Li, X., Wang, X., Li, X., Zhang, Z., & Wang, Y. (2012). UCP2 inhibits ROS-mediated apoptosis in A549 under hypoxic conditions. PLOS One, 7, e30714."}, {"Citation": "Doherty, J. R., Yang, C., Scott, K. E. N., Cameron, M. D., Fallahi, M., Li, W., Hall, M. A., Amelio, A. L., Mishra, J. K., Li, F., Tortosa, M., Genau, H. M., Rounbehler, R. J., Lu, Y., Dang, C. V., Kumar, K. G., Butler, A. A., Bannister, T. D., Hooper, A. T., \u2026 Cleveland, J. L. (2014). Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis. Cancer Research, 74, 908-920."}, {"Citation": "D\u00fcvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., Vander Heiden, M. G., MacKeigan, J. P., Finan, P. M., Clish, C. B., Murphy, L. O., & Manning, B. D. (2010). Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Molecular Cell, 39, 171-183."}, {"Citation": "Eales, K. L., Hollinshead, K. E., & Tennant, D. A. (2016). Hypoxia and metabolic adaptation of cancer cells. Oncogenesis, 5, e190."}, {"Citation": "Emmanuel, N., Ragunathan, S., Shan, Q., Wang, F., Giannakou, A., Huser, N., Jin, G., Myers, J., Abraham, R. T., & Unsal-Kacmaz, K. (2017). Purine nucleotide availability regulates mTORC1 activity through the Rheb GTPase. Cell Reports, 19, 2665-2680."}, {"Citation": "Firuzi, O., Miri, R., Tavakkoli, M., & Saso, L. (2011). Antioxidant therapy: Current status and future prospects. Current Medicinal Chemistry, 18, 3871-3888."}, {"Citation": "Foldi, M., Stickeler, E., Bau, L., Kretz, O., Watermann, D., Gitsch, G., Kayser, G., Zur Hausen, A., & Coy, J. F. (2007). Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer. Oncology Reports, 17, 841-845."}, {"Citation": "Freed-Pastor, W. A., Mizuno, H., Zhao, X., Langer\u00f8d, A., Moon, S. H., Rodriguez-Barrueco, R., Barsotti, A., Chicas, A., Li, W., Polotskaia, A., Bissell, M. J., Osborne, T. F., Tian, B., Lowe, S. W., Silva, J. M., B\u00f8rresen-Dale, A. L., Levine, A. J., Bargonetti, J., & Prives, C. (2012). Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell, 148, 244-258."}, {"Citation": "Fruman, D. A., Chiu, H., Hopkins, B. D., Bagrodia, S., Cantley, L. C., & Abraham, R. T. (2017). The PI3K pathway in human disease. Cell, 170, 605-635."}, {"Citation": "Fuchs-Tarlovsky, V. (2013). Role of antioxidants in cancer therapy. Nutrition, 29, 15-21."}, {"Citation": "Furuta, E., Pai, S. K., Zhan, R., Bandyopadhyay, S., Watabe, M., Mo, Y. Y., Hirota, S., Hosobe, S., Tsukada, T., Miura, K., Kamada, S., Saito, K., Iiizumi, M., Liu, W., Ericsson, J., & Watabe, K. (2008). Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Research, 68, 1003-1011."}, {"Citation": "Gaglio, D., Soldati, C., Vanoni, M., Alberghina, L., & Chiaradonna, F. (2009). Glutamine deprivation induces abortive s-phase rescued by deoxyribonucleotides in k-ras transformed fibroblasts. PLOS One, 4, e4715."}, {"Citation": "Gallagher, E. J., Zelenko, Z., Neel, B. A., Antoniou, I. M., Rajan, L., Kase, N., & LeRoith, D. (2017). Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia. Oncogene, 36, 6462-6471."}, {"Citation": "Gao, P., Tchernyshyov, I., Chang, T. C., Lee, Y. S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., & Dang, C. V. (2009). c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature, 458, 762-765."}, {"Citation": "Gao, Y., Yang, F., Yang, X. A., Zhang, L., Yu, H., Cheng, X., Xu, S., Pan, J., Wang, K., & Li, P. (2019). Mitochondrial metabolism is inhibited by the HIF1alpha-MYC-PGC-1beta axis in BRAF V600E thyroid cancer. The FEBS Journal, 286, 1420-1436."}, {"Citation": "Gao, Y., Zhou, S., Xu, Y., Sheng, S., Qian, S. Y., & Huo, X. (2019). Nitric oxide synthase inhibitors 1400W and L-NIO inhibit angiogenesis pathway of colorectal cancer. Nitric Oxide: Biology and Chemistry, 83, 33-39."}, {"Citation": "Giordano, A., Calvani, M., Petillo, O., Grippo, P., Tuccillo, F., Melone, M. A., Bonelli, P., Calarco, A., & Peluso, G. (2005). tBid induces alterations of mitochondrial fatty acid oxidation flux by malonyl-CoA-independent inhibition of carnitine palmitoyltransferase-1. Cell Death and Differentiation, 12, 603-613."}, {"Citation": "Goldar, S., Khaniani, M. S., Derakhshan, S. M., & Baradaran, B. (2015). Molecular mechanisms of apoptosis and roles in cancer development and treatment. Asian Pacific Journal of Cancer Prevention, 16, 2129-2144."}, {"Citation": "Gonzalez, P. S., O\u2032Prey, J., Cardaci, S., Barthet, V. J. A., Sakamaki, J., Beaumatin, F., Roseweir, A., Gay, D. M., Mackay, G., Malviya, G., Kania, E., Ritchie, S., Baudot, A. D., Zunino, B., Mrowinska, A., Nixon, C., Ennis, D., Hoyle, A., Millan, D., \u2026 Ryan, K. M. (2018). Mannose impairs tumour growth and enhances chemotherapy. Nature, 563, 719-723."}, {"Citation": "Gottlieb, T. M., Leal, J. F., Seger, R., Taya, Y., & Oren, M. (2002). Cross-talk between Akt, p53 and Mdm2: Possible implications for the regulation of apoptosis. Oncogene, 21, 1299-1303."}, {"Citation": "Gouw, A. M., Eberlin, L. S., Margulis, K., Sullivan, D. K., Toal, G. G., Tong, L., Zare, R. N., & Felsher, D. W. (2017). Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma. Proceedings of the National Academy of Sciences of the United States of America, 114, 4300-4305."}, {"Citation": "Gu, Y., Albuquerque, C. P., Braas, D., Zhang, W., Villa, G. R., Bi, J., Ikegami, S., Masui, K., Gini, B., Yang, H., Gahman, T. C., Shiau, A. K., Cloughesy, T. F., Christofk, H. R., Zhou, H., Guan, K. L., & Mischel, P. S. (2017). mTORC2 regulates amino acid metabolism in cancer by phosphorylation of the cystine-glutamate antiporter xCT. Molecular Cell, 67, 128-138 e127."}, {"Citation": "Guan, L., Chen, Y., Wang, Y., Zhang, H., Fan, S., Gao, Y., Jiao, T., Fu, K., Sun, J., Yu, A., Huang, M., & Bi, H. (2019). Effects of carnitine palmitoyltransferases on cancer cellular senescence. Journal of Cellular Physiology, 234, 1707-1719."}, {"Citation": "Guo, D., Bell, E. H., Mischel, P., & Chakravarti, A. (2014). Targeting SREBP-1-driven lipid metabolism to treat cancer. Current Pharmaceutical Design, 20, 2619-2626."}, {"Citation": "Guo, D., Reinitz, F., Youssef, M., Hong, C., Nathanson, D., Akhavan, D., Kuga, D., Amzajerdi, A. N., Soto, H., Zhu, S., Babic, I., Tanaka, K., Dang, J., Iwanami, A., Gini, B., DeJesus, J., Lisiero, D. D., Huang, T. T., Prins, R. M., \u2026 Mischel, P. S. (2011). An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. Cancer Discovery, 1, 442-456."}, {"Citation": "Hagner, N., & Joerger, M. (2010). Cancer chemotherapy: Targeting folic acid synthesis. Cancer Management and Research, 2, 293-301."}, {"Citation": "Han, W., & Liu, J. (2018). LncRNA-p21 inhibited the proliferation of osteosarcoma cells via the miR-130b/PTEN/AKT signaling pathway. Biomedicine & Pharmacotherapy, 97, 911-918."}, {"Citation": "Hawk, M. A., McCallister, C., & Schafer, Z. T. (2016). Antioxidant activity during tumor progression: A necessity for the survival of cancer cells? Cancers, 8, 8."}, {"Citation": "Hay, N. (2016). Reprogramming glucose metabolism in cancer: Can it be exploited for cancer therapy? Nature Reviews Cancer, 16, 635-649."}, {"Citation": "He, D., Sun, X., Yang, H., Li, X., & Yang, D. (2018). TOFA induces cell cycle arrest and apoptosis in ACHN and 786-O cells through inhibiting PI3K/Akt/mTOR pathway. Journal of Cancer, 9, 2734-2742."}, {"Citation": "He, G., Jiang, Y., Zhang, B., & Wu, G. (2014). The effect of HIF-1alpha on glucose metabolism, growth and apoptosis of pancreatic cancerous cells. Asia Pacific Journal of Clinical Nutrition, 23, 174-180."}, {"Citation": "Hemmings, B. A., & Restuccia, D. F. (2012). PI3K-PKB/Akt pathway. Cold Spring Harbor Perspectives in Biology, 4, a011189."}, {"Citation": "Hitosugi, T., Zhou, L., Elf, S., Fan, J., Kang, H. B., Seo, J. H., Shan, C., Dai, Q., Zhang, L., Xie, J., Gu, T. L., Jin, P., Ale\u010dkovi\u0107, M., LeRoy, G., Kang, Y., Sudderth, J. A., DeBerardinis, R. J., Luan, C. H., Chen, G. Z., \u2026 Chen, J. (2012). Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. Cancer Cell, 22, 585-600."}, {"Citation": "Hong, S. Y., Yu, F. X., Luo, Y., & Hagen, T. (2016). Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein. Cellular Signalling, 28, 377-383."}, {"Citation": "Hornsveld, M., & Dansen, T. B. (2016). The Hallmarks of cancer from a redox perspective. Antioxidants & Redox Signaling, 25, 300-325."}, {"Citation": "Hu, X., Chao, M., & Wu, H. (2017). Central role of lactate and proton in cancer cell resistance to glucose deprivation and its clinical translation. Signal Transduction and Targeted Therapy, 2, 16047."}, {"Citation": "Hua, H., Zhang, H., Kong, Q., Wang, J., & Jiang, Y. (2019). Complex roles of the old drug aspirin in cancer chemoprevention and therapy. Medicinal Research Reviews, 39, 114-145."}, {"Citation": "Huang, J., & Manning, B. D. (2009). A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochemical Society Transactions, 37, 217-222."}, {"Citation": "Iadevaia, V., Liu, R., & Proud, C. G. (2014). mTORC1 signaling controls multiple steps in ribosome biogenesis. Seminars in Cell & Developmental Biology, 36, 113-120."}, {"Citation": "Iommarini, L., Ghelli, A., Gasparre, G., & Porcelli, A. M. (2017). Mitochondrial metabolism and energy sensing in tumor progression. Biochimica et Biophysica Acta. Bioenergetics, 1858, 582-590."}, {"Citation": "Iranzo, J., Martincorena, I., & Koonin, E. V. (2018). Cancer-mutation network and the number and specificity of driver mutations. Proceedings of the National Academy of Sciences of the United States of America, 115, E6010-E6019."}, {"Citation": "Ishak Gabra, M. B., Yang, Y., Lowman, X. H., Reid, M. A., Tran, T. Q., & Kong, M. (2018). IKKbeta activates p53 to promote cancer cell adaptation to glutamine deprivation. Oncogenesis, 7, 93."}, {"Citation": "Israelsen, W. J., Dayton, T. L., Davidson, S. M., Fiske, B. P., Hosios, A. M., Bellinger, G., Li, J., Yu, Y., Sasaki, M., Horner, J. W., Burga, L. N., Xie, J., Jurczak, M. J., DePinho, R. A., Clish, C. B., Jacks, T., Kibbey, R. G., Wulf, G. M., Di Vizio, D., \u2026 Vander Heiden, M. G. (2013). PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell, 155, 397-409."}, {"Citation": "Jain, M. V., Paczulla, A. M., Klonisch, T., Dimgba, F. N., Rao, S. B., Roberg, K., Schweizer, F., Lengerke, C., Davoodpour, P., Palicharla, V. R., Maddika, S., & \u0141os, M. (2013). Interconnections between apoptotic, autophagic and necrotic pathways: Implications for cancer therapy development. Journal of Cellular and Molecular Medicine, 17, 12-29."}, {"Citation": "Jang, G. B., Kim, J. Y., Cho, S. D., Park, K. S., Jung, J. Y., Lee, H. Y., Hong, I. S., & Nam, J. S. (2015). Blockade of Wnt/beta-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype. Scientific Reports, 5, 12465."}, {"Citation": "Jiang, B. (2017). Aerobic glycolysis and high level of lactate in cancer metabolism and microenvironment. Genes & Diseases, 4, 25-27."}, {"Citation": "Jiang, P., Du, W., Wang, X., Mancuso, A., Gao, X., Wu, M., & Yang, X. (2011). p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nature Cell Biology, 13, 310-316."}, {"Citation": "Jiang, X., Sun, Q., Li, H., Li, K., & Ren, X. (2014). The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications. International Journal of Cancer, 135, 1991-1996."}, {"Citation": "Jie, Z., Xie, Z., Xu, W., Zhao, X., Jin, G., Sun, X., Huang, B., Tang, P., Wang, G., Shen, S., Qin, A., & Fan, S. (2019). SREBP-2 aggravates breast cancer associated osteolysis by promoting osteoclastogenesis and breast cancer metastasis. Biochimica et Biophysica Acta Molecular Basis of Disease, 1865, 115-125."}, {"Citation": "Jin, H. R., Du, C. H., Wang, C. Z., Yuan, C. S., & Du, W. (2019). Ginseng metabolite protopanaxadiol interferes with lipid metabolism and induces endoplasmic reticulum stress and p53 activation to promote cancer cell death. Phytotherapy Research, 33, 610-617."}, {"Citation": "Jin, S. Y., Lee, H. S., Kim, E. K., Ha, J. M., Kim, Y. W., & Bae, S. (2014). Reactive oxygen species and PI3K/Akt signaling in cancer. Free Radical Biology and Medicine, 75(Suppl. 1), S34-S35."}, {"Citation": "Jones, C. L., Stevens, B. M., D'Alessandro, A., Reisz, J. A., Culp-Hill, R., Nemkov, T., Pei, S., Khan, N., Adane, B., Ye, H., Krug, A., Reinhold, D., Smith, C., DeGregori, J., Pollyea, D. A., & Jordan, C. T. (2018). Inhibition of amino acid metabolism selectively targets human leukemia stem cells. Cancer Cell, 34, e724-740.e4"}, {"Citation": "Jun, J. C., Rathore, A., Younas, H., Gilkes, D., & Polotsky, V. Y. (2017). Hypoxia-inducible factors and cancer. Current Sleep Medicine Reports, 3, 1-10."}, {"Citation": "Jung, B. J., Yoo, H. S., Shin, S., Park, Y. J., & Jeon, S. M. (2018). Dysregulation of NRF2 in Cancer: From molecular mechanisms to therapeutic opportunities. Biomolecules & Therapeutics, 26, 57-68."}, {"Citation": "Kawauchi, K., Araki, K., Tobiume, K., & Tanaka, N. (2008). p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation. Nature Cell Biology, 10, 611-618."}, {"Citation": "Khan, P., Bhattacharya, A., Sengupta, D., Banerjee, S., Adhikary, A., & Das, T. (2019). Aspirin enhances cisplatin sensitivity of resistant non-small cell lung carcinoma stem-like cells by targeting mTOR-Akt axis to repress migration. Scientific Reports, 9, 16913."}, {"Citation": "Kheirandish, M., Mahboobi, H., Yazdanparast, M., Kamal, W., & Kamal, M. A. (2018). Anti-cancer effects of metformin: Recent evidences for its role in prevention and treatment of cancer. Current Drug Metabolism, 19, 793-797."}, {"Citation": "Kim, E. K., & Choi, E. J. (2010). Pathological roles of MAPK signaling pathways in human diseases. Biochimica et Biophysica Acta, 1802, 396-405."}, {"Citation": "Kollareddy, M., Dimitrova, E., Vallabhaneni, K. C., Chan, A., Le, T., Chauhan, K. M., Carrero, Z. I., Ramakrishnan, G., Watabe, K., Haupt, Y., Haupt, S., Pochampally, R., Boss, G. R., Romero, D. G., Radu, C. G., & Martinez, L. A. (2015). Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities. Nature Communications, 6, 7389."}, {"Citation": "Koolivand, M., Ansari, M., Piroozian, F., Moein, S., & MalekZadeh, K. (2018). Alleviating the progression of acute myeloid leukemia (AML) by sulforaphane\u00a0through controlling miR-155 levels. Molecular Biology Reports, 45, 2491-2499."}, {"Citation": "Kryston, T. B., Georgiev, A. B., Pissis, P., & Georgakilas, A. G. (2011). Role of oxidative stress and DNA damage in human carcinogenesis. Mutation Research, 711, 193-201."}, {"Citation": "Kuemmerle, N. B., Rysman, E., Lombardo, P. S., Flanagan, A. J., Lipe, B. C., Wells, W. A., Pettus, J. R., Froehlich, H. M., Memoli, V. A., Morganelli, P. M., Swinnen, J. V., Timmerman, L. A., Chaychi, L., Fricano, C. J., Eisenberg, B. L., Coleman, W. B., & Kinlaw, W. B. (2011). Lipoprotein lipase links dietary fat to solid tumor cell proliferation. Molecular Cancer Therapeutics, 10, 427-436."}, {"Citation": "Kumar, J. P., & Mandal, B. B. (2019). Silk sericin induced pro-oxidative stress leads to apoptosis in human cancer cells. Food and Chemical Toxicology, 123, 275-287."}, {"Citation": "Kuzu, O. F., Noory, M. A., & Robertson, G. P. (2016). The role of cholesterol in cancer. Cancer Research, 76, 2063-2070."}, {"Citation": "Lee, H. J., Li, J., Vickman, R. E., Li, J., Liu, R., Durkes, A. C., Elzey, B. D., Yue, S., Liu, X., Ratliff, T. L., & Cheng, J. X. (2018). Cholesterol esterification inhibition suppresses prostate cancer metastasis by impairing the Wnt/beta-catenin pathway. Molecular Cancer Research, 16, 974-985."}, {"Citation": "Lee, J., Yesilkanal, A. E., Wynne, J. P., Frankenberger, C., Liu, J., Yan, J., Elbaz, M., Rabe, D. C., Rustandy, F. D., Tiwari, P., Grossman, E. A., Hart, P. C., Kang, C., Sanderson, S. M., Andrade, J., Nomura, D. K., Bonini, M. G., Locasale, J. W., & Rosner, M. R. (2019). Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism. Nature, 568, 254-258."}, {"Citation": "Lee, J. H., Liu, R., Li, J., Zhang, C., Wang, Y., Cai, Q., Qian, X., Xia, Y., Zheng, Y., Piao, Y., Chen, Q., de Groot, J. F., Jiang, T., & Lu, Z. (2017). Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis. Nature Communications, 8, 949."}, {"Citation": "Li, C., He, C., Xu, Y., Xu, H., Tang, Y., Chavan, H., Duan, S., Artigues, A., Forrest, M. L., Krishnamurthy, P., Han, S., Holzbeierlein, J. M., & Li, B. (2019). Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer. The Prostate, 79, 628-639."}, {"Citation": "Li, D., Wang, P., Yu, Y., Huang, B., Zhang, X., Xu, C., Zhao, X., Yin, Z., He, Z., Jin, M., & Liu, C. (2018). Tumor-preventing activity of aspirin in multiple cancers based on bioinformatic analyses. PeerJ, 6, e5667."}, {"Citation": "Li, J., Gu, D., Lee, S. S. Y., Song, B., Bandyopadhyay, S., Chen, S., Konieczny, S. F., Ratliff, T. L., Liu, X., Xie, J., & Cheng, J. X. (2016). Abrogating\u00a0cholesterol esterification suppresses growth and metastasis of pancreatic cancer. Oncogene, 35, 6378-6388."}, {"Citation": "Li, R. J., Xu, J., Fu, C., Zhang, J., Zheng, Y. G., Jia, H., & Liu, J. O. (2016). Regulation of mTORC1 by lysosomal calcium and calmodulin. eLife, 5."}, {"Citation": "Li, S. (2005). Mechanisms of cellular signal transduction. International Journal of Biological Sciences, 1, 152."}, {"Citation": "Liang, J., Zubovitz, J., Petrocelli, T., Kotchetkov, R., Connor, M. K., Han, K., Lee, J. H., Ciarallo, S., Catzavelos, C., Beniston, R., Franssen, E., & Slingerland, J. M. (2002). PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nature Medicine, 8, 1153-1160."}, {"Citation": "Lin, J., Yang, T., Peng, Z., Xiao, H., Jiang, N., Zhang, L., Ca, D., Wu, P., & Pan, Q. (2018). SLC1A5 silencing inhibits esophageal cancer growth via cell cycle arrest and apoptosis. Cellular Physiology and Biochemistry, 48, 397."}, {"Citation": "Little, J. L., & Kridel, S. J. (2008). Fatty acid synthase activity in tumor cells. Sub-Cellular Biochemistry, 49, 169-194."}, {"Citation": "Liu, J., Zhang, C., Hu, W., & Feng, Z. (2019). Tumor suppressor\u00a0p53 and metabolism. Journal of Molecular Cell Biology, 11(4), 284-292."}, {"Citation": "Liu, W., Le, A., Hancock, C., Lane, A. N., Dang, C. V., Fan, T. W., & Phang, J. M. (2012). Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proceedings of the National Academy of Sciences of the United States of America, 109, 8983-8988."}, {"Citation": "Liu, Y., Feng, J., Sun, M., Liu, B., Yang, G., Bu, Y., Zhao, M., Wang, T., Zhang, W., Yuan, H., & Zhang, X. (2019). Aspirin inhibits the proliferation of hepatoma cells through controlling GLUT1-mediated glucose metabolism. Acta Pharmacologica Sinica, 40, 122-132."}, {"Citation": "Liu, Z., Wu, X., Lv, J., Sun, H., & Zhou, F. (2019). Resveratrol induces p53 in colorectal cancer through SET7/9. Oncology Letters, 17, 3783-3789."}, {"Citation": "Locasale, J. W., Grassian, A. R., Melman, T., Lyssiotis, C. A., Mattaini, K. R., Bass, A. J., Heffron, G., Metallo, C. M., Muranen, T., Sharfi, H., Sasaki, A. T., Anastasiou, D., Mullarky, E., Vokes, N. I., Sasaki, M., Beroukhim, R., Stephanopoulos, G., Ligon, A. H., Meyerson, M., \u2026 Vander Heiden, M. G. (2011). Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nature Genetics, 43, 869-874."}, {"Citation": "Lu, J., Wang, L., Chen, W., Wang, Y., Zhen, S., Chen, H., Cheng, J., Zhou, Y., Li, X., & Zhao, L. (2019). miR-603 targeted hexokinase-2 to inhibit the malignancy of ovarian cancer cells. Archives of Biochemistry and Biophysics, 661, 1-9."}, {"Citation": "Lubos, E., Loscalzo, J., & Handy, D. E. (2011). Glutathione peroxidase-1 in health and disease: From molecular mechanisms to therapeutic opportunities. Antioxidants & Redox Signaling, 15, 1957-1997."}, {"Citation": "Luke, J. J., Ott, P. A., & Shapiro, G. I. (2014). The biology and clinical development of MEK inhibitors for cancer. Drugs, 74, 2111-2128."}, {"Citation": "Ma, X., Li, B., Liu, J., Fu, Y., & Luo, Y. (2019). Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E. Journal of Experimental & Clinical Cancer Research, 38, 66."}, {"Citation": "MacDonald, B. T., Tamai, K., & He, X. (2009). Wnt/beta-catenin signaling: Components, mechanisms, and diseases. Developmental Cell, 17, 9-26."}, {"Citation": "Maddocks, O. D., Berkers, C. R., Mason, S. M., Zheng, L., Blyth, K., Gottlieb, E., & Vousden, K. H. (2013). Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature, 493, 542-546."}, {"Citation": "Maertens, O., & Cichowski, K. (2014). An expanding role for RAS GTPase activating proteins (RAS GAPs) in cancer. Advances in Biological Regulation, 55, 1-14."}, {"Citation": "Makinoshima, H., Takita, M., Saruwatari, K., Umemura, S., Obata, Y., Ishii, G., Matsumoto, S., Sugiyama, E., Ochiai, A., Abe, R., Goto, K., Esumi, H., & Tsuchihara, K. (2015). Signaling through the phosphatidylinositol 3-Kinase (PI3K)/mammalian target of rapamycin (mTOR) axis is responsible for aerobic glycolysis mediated by glucose transporter in epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma. The Journal of Biological Chemistry, 290, 17495-17504."}, {"Citation": "Manning, B. D., & Toker, A. (2017). AKT/PKB signaling: Navigating the network. Cell, 169, 381-405."}, {"Citation": "Martin, G. S. (2003). Cell signaling and cancer. Cancer Cell, 4, 167-174."}, {"Citation": "Mazidi, M., Ferns, G. A., & Banach, M. (2020). A high consumption of tomato and lycopene is associated with a lower risk of cancer mortality: Results from a multi-ethnic cohort. Public Health Nutrition, 23, 1-7."}, {"Citation": "McMahon, S. B. (2008). ). Control of nucleotide biosynthesis by the MYC oncoprotein. Cell Cycle, 7, 2275-2276."}, {"Citation": "Menendez, J. A., Vellon, L., Mehmi, I., Oza, B. P., Ropero, S., Colomer, R., & Lupu, R. (2004). Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 101, 10715-10720."}, {"Citation": "Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., Kelleher, J. K., Vander Heiden, M. G., Iliopoulos, O., & Stephanopoulos, G. (2011). Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature, 481, 380-384."}, {"Citation": "Miao, G., Han, J., Zhang, J., Wu, Y., & Tong, G. (2019). Targeting pyruvate kinase M2 and hexokinase II, pachymic acid impairs glucose metabolism and induces mitochondrial apoptosis. Biological & Pharmaceutical Bulletin, 42, 123-129."}, {"Citation": "Milella, M., Falcone, I., Conciatori, F., Cesta Incani, U., Del Curatolo, A., Inzerilli, N., Nuzzo, C. M. A., Vaccaro, V., Vari, S., Cognetti, F., & Ciuffreda, L. (2015). PTEN: Multiple functions in human malignant tumors. Frontiers in Oncology, 5, 24."}, {"Citation": "Minchenko, A., Leshchinsky, I., Opentanova, I., Sang, N., Srinivas, V., Armstead, V., & Caro, J. (2002). Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. The Journal of Biological Chemistry, 277, 6183-6187."}, {"Citation": "Moein, S., Pimoradloo, E., Moein, M., & Vessal, M. (2017). Evaluation of antioxidant potentials and alpha-amylase inhibition of different fractions of labiatae plants extracts: As a model of antidiabetic compounds properties. BioMed Research International, 2017, 7319504-7319508."}, {"Citation": "Moradi-Marjaneh, R., Hassanian, S. M., Mehramiz, M., Rezayi, M., Ferns, G. A., Khazaei, M., & Avan, A. (2019). Reactive oxygen species in colorectal cancer: The therapeutic impact and its potential roles in tumor progression via perturbation of cellular and physiological dysregulated pathways. Journal of Cellular Physiology, 234, 10072-10079."}, {"Citation": "Moreno-Sanchez, R., Gallardo-Perez, J. C., Rodriguez-Enriquez, S., Saavedra, E., & Marin-Hernandez, A. (2017). Control of the NADPH supply for oxidative stress handling in cancer cells. Free Radical Biology & Medicine, 112, 149-161."}, {"Citation": "Murata, S., Yanagisawa, K., Fukunaga, K., Oda, T., Kobayashi, A., Sasaki, R., & Ohkohchi, N. (2010). Fatty acid synthase inhibitor cerulenin suppresses liver metastasis of colon cancer in mice. Cancer Science, 101, 1861-1865."}, {"Citation": "Mylonis, I., Simos, G., & Paraskeva, E. (2019). Hypoxia-inducible factors and the regulation of lipid metabolism. Cells, 8, 8."}, {"Citation": "Nakashima, C., Yamamoto, K., Fujiwara-Tani, R., Luo, Y., Matsushima, S., Fujii, K., Ohmori, H., Sasahira, T., Sasaki, T., Kitadai, Y., Kirita, T., & Kuniyasu, H. (2018). Expression of cytosolic malic enzyme (ME1) is associated with disease progression in human oral squamous cell carcinoma. Cancer Science, 109, 2036-2045."}, {"Citation": "Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., Yang, H., Hild, M., Kung, C., Wilson, C., Myer, V. E., MacKeigan, J. P., Porter, J. A., Wang, Y. K., Cantley, L. C., Finan, P. M., & Murphy, L. O. (2009). Bidirectional transport of amino acids regulates mTOR and autophagy. Cell, 136, 521-534."}, {"Citation": "Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., Yamada, S. D., Peter, M. E., Gwin, K., & Lengyel, E. (2011). Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nature Medicine, 17, 1498-1503."}, {"Citation": "Nishi, K., Suzuki, M., Yamamoto, N., Matsumoto, A., Iwase, Y., Yamasaki, K., Otagiri, M., & Yumita, N. (2018). Glutamine deprivation enhances acetyl-CoA carboxylase inhibitor-induced death of human pancreatic cancer cells. Anticancer Research, 38, 6683-6689."}, {"Citation": "Nogueira, V., Patra, K. C., & Hay, N. (2018). Selective eradication of cancer displaying hyperactive Akt by exploiting the metabolic consequences of Akt activation. eLife, 7."}, {"Citation": "Nowotarski, S. L., Woster, P. M., & Casero, R. A., Jr. (2013). Polyamines and cancer: Implications for chemotherapy and chemoprevention. Expert Reviews in Molecular Medicine, 15, e3."}, {"Citation": "Ogawara, Y., Kishishita, S., Obata, T., Isazawa, Y., Suzuki, T., Tanaka, K., Masuyama, N., & Gotoh, Y. (2002). Akt enhances Mdm2-mediated ubiquitination and degradation of p53. The Journal of Biological Chemistry, 277, 21843-21850."}, {"Citation": "Olas, B., & Wachowicz, B. (2005). Resveratrol, a phenolic antioxidant with effects on blood platelet functions. Platelets, 16, 251-260."}, {"Citation": "Origanti, S., Nowotarski, S. L., Carr, T. D., Sass-Kuhn, S., Xiao, L., Wang, J. Y., & Shantz, L. M. (2012). Ornithine decarboxylase mRNA is stabilized in an mTORC1-dependent manner in Ras-transformed cells. The Biochemical Journal, 442, 199-207."}, {"Citation": "Osthus, R. C., Shim, H., Kim, S., Li, Q., Reddy, R., Mukherjee, M., Xu, Y., Wonsey, D., Lee, L. A., & Dang, C. V. (2000). Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. The Journal of Biological Chemistry, 275, 21797-21800."}, {"Citation": "Ou, Y., Wang, S. J., Jiang, L., Zheng, B., & Gu, W. (2015). p53 Protein-mediated regulation of phosphoglycerate dehydrogenase (PHGDH) is crucial for the apoptotic response upon serine starvation. The Journal of Biological Chemistry, 290, 457-466."}, {"Citation": "Pai, S. G., Carneiro, B. A., Mota, J. M., Costa, R., Leite, C. A., Barroso-Sousa, R., Kaplan, J. B., Chae, Y. K., & Giles, F. J. (2017). Wnt/beta-catenin pathway: Modulating anticancer immune response. Journal of Hematology & Oncology, 10, 101."}, {"Citation": "Pastorino, J. G., Shulga, N., & Hoek, J. B. (2002). Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. The Journal of Biological Chemistry, 277, 7610-7618."}, {"Citation": "Pate, K. T., Stringari, C., Sprowl-Tanio, S., Wang, K., TeSlaa, T., Hoverter, N. P., McQuade, M. M., Garner, C., Digman, M. A., Teitell, M. A., Edwards, R. A., Gratton, E., & Waterman, M. L. (2014). Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. The EMBO Journal, 33, 1454-1473."}, {"Citation": "Pedone, E., & Marucci, L. (2019). Role of beta-catenin activation levels and fluctuations in controlling cell fate. Genes, 10(2), 176."}, {"Citation": "Pereira, C. V., Duarte, M., Silva, P., Bento da Silva, A., Duarte, C. M. M., Cifuentes, A., Garcia-Canas, V., Bronze, M. R., Albuquerque, C., & Serra, A. T. (2019). Polymethoxylated flavones target cancer stemness and improve the antiproliferative effect of 5-fluorouracil in a 3D cell model of colorectal cancer. Nutrients, 11, 11."}, {"Citation": "Phan, L. M., Yeung, S. C., & Lee, M. H. (2014). Cancer metabolic reprogramming: Importance, main features, and potentials for precise targeted anti-cancer therapies. Cancer Biology & Medicine, 11, 1-19."}, {"Citation": "Phang, J. M., Liu, W., Hancock, C. N., & Fischer, J. W. (2015). Proline metabolism and cancer: Emerging links to glutamine and collagen. Current Opinion in Clinical Nutrition and Metabolic Care, 18, 71-77."}, {"Citation": "Pike, L. S., Smift, A. L., Croteau, N. J., Ferrick, D. A., & Wu, M. (2011). Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochimica et Biophysica Acta, 1807, 726-734."}, {"Citation": "Porstmann, T., Santos, C. R., Griffiths, B., Cully, M., Wu, M., Leevers, S., Griffiths, J. R., Chung, Y. L., & Schulze, A. (2008). SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metabolism, 8, 224-236."}, {"Citation": "Porta, C., Paglino, C., & Mosca, A. (2014). Targeting PI3K/Akt/mTOR signaling in cancer. Frontiers in Oncology, 4, 64."}, {"Citation": "Potter, M., Newport, E., & Morten, K. J. (2016). The Warburg effect: 80 years on. Biochemical Society Transactions, 44, 1499-1505."}, {"Citation": "Rahmani, F., Ferns, G. A., Talebian, S., Nourbakhsh, M., Avan, A., & Shahidsales, S. (2020). Role of regulatory miRNAs of the PI3K/AKT signaling pathway in the pathogenesis of breast cancer. Gene, 737, 144459."}, {"Citation": "Reid, M. A., & Kong, M. (2013). Dealing with hunger: Metabolic stress responses in tumors. Journal of Carcinogenesis, 12, 17."}, {"Citation": "Ren, P., Yue, M., Xiao, D., Xiu, R., Gan, L., Liu, H., & Qing, G. (2015). ATF4 and N-Myc coordinate glutamine metabolism in MYCN-amplified neuroblastoma cells through ASCT2 activation. The Journal of Pathology, 235, 90-100."}, {"Citation": "Ren, X., Santhosh, S. M., Coppo, L., Ogata, F. T., Lu, J., & Holmgren, A. (2019). The combination of ascorbate and menadione causes cancer cell death by oxidative stress and replicative stress. Free Radical Biology & Medicine, 134, 350-358."}, {"Citation": "Rodbell, M. (1980). The role of hormone receptors and GTP-regulatory proteins in membrane transduction. Nature, 284, 17-22."}, {"Citation": "Rossig, L., Jadidi, A. S., Urbich, C., Badorff, C., Zeiher, A. M., & Dimmeler, S. (2001). Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. Molecular and Cellular Biology, 21, 5644-5657."}, {"Citation": "Rouzbehan, S., Moein, S., Homaei, A., & Moein, M. R. (2017). Kinetics of alpha-glucosidase inhibition by different fractions of three species of Labiatae extracts: A new diabetes treatment model. Pharmaceutical Biology, 55, 1483-1488."}, {"Citation": "Roy, P. S., & Saikia, B. J. (2016). Cancer and cure: A critical analysis. Indian Journal of Cancer, 53, 441-442."}, {"Citation": "Saladini, S., Aventaggiato, M., Barreca, F., Morgante, E., Sansone, L., Russo, M. A., & Tafani, M. (2019). Metformin impairs glutamine metabolism and autophagy in tumour cells. Cells, 8, 8."}, {"Citation": "Samanta, D., & Semenza, G. L. (2018). Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors. Biochimica et Biophysica Acta: Reviews on Cancer, 1870, 15-22."}, {"Citation": "Samatar, A. A., & Poulikakos, P. I. (2014). Targeting RAS-ERK signalling in cancer: Promises and challenges. Nature Reviews Drug Discovery, 13, 928-942."}, {"Citation": "Samavarchi Tehrani, S., Mahmoodzadeh Hosseini, H., Yousefi, T., Abolghasemi, M., Qujeq, D., Maniati, M., & Amani, J. (2018). The crosstalk\u00a0between trace elements with DNA damage response, repair, and oxidative stress in cancer. Journal of Cellular Biochemistry."}, {"Citation": "San-Millan, I., & Brooks, G. A. (2017). Reexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg effect. Carcinogenesis, 38, 119-133."}, {"Citation": "Sasaki, H., Shitara, M., Yokota, K., Hikosaka, Y., Moriyama, S., Yano, M., & Fujii, Y. (2012). Overexpression of GLUT1 correlates with Kras mutations in lung carcinomas. Molecular Medicine Reports, 5, 599-602."}, {"Citation": "Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., & Brugge, J. S. (2009). Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature, 461, 109-113."}, {"Citation": "Semenza, G. L. (2003). Targeting HIF-1 for cancer therapy. Nature Reviews Cancer, 3, 721-732."}, {"Citation": "Semenza, G. L. (2013). HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. The Journal of Clinical Investigation, 123, 3664-3671."}, {"Citation": "Senni, N., Savall, M., Cabrerizo Granados, D., Alves-Guerra, M. C., Sartor, C., Lagoutte, I., Gougelet, A., Terris, B., Gilgenkrantz, H., Perret, C., Colnot, S., & Bossard, P. (2019). Beta-catenin-activated hepatocellular carcinomas are addicted to fatty acids. Gut, 68, 322-334."}, {"Citation": "Sharma, A., Bandyopadhayaya, S., Chowdhury, K., Sharma, T., Maheshwari, R., Das, A., Chakrabarti, G., Kumar, V., & Mandal, C. C. (2019). Metformin exhibited anticancer activity by lowering cellular cholesterol content in breast cancer cells. PLOS One, 14, e0209435."}, {"Citation": "Shen, P., Reineke, L. C., Knutsen, E., Chen, M., Pichler, M., Ling, H., & Calin, G. A. (2018). Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK1-eIF4G-eIF4E signaling. Molecular Oncology, 12, 1856-1870."}, {"Citation": "Shim, H., Dolde, C., Lewis, B. C., Wu, C. S., Dang, G., Jungmann, R. A., Dalla-Favera, R., & Dang, C. V. (1997). c-Myc transactivation of LDH-A: Implications for tumor metabolism and growth. Proceedings of the National Academy of Sciences of the United States of America, 94, 6658-6663."}, {"Citation": "Shimano, H. (2001). Sterol regulatory element-binding proteins (SREBPs): Transcriptional regulators of lipid synthetic genes. Progress in Lipid Research, 40, 439-452."}, {"Citation": "Siegel, R. L., Miller, K. D., & Jemal, A. (2018). Cancer statistics, 2018. CA: A Cancer Journal for Clinicians, 68, 7-30."}, {"Citation": "Singh, D., Arora, R., Kaur, P., Singh, B., Mannan, R., & Arora, S. (2017). Overexpression of hypoxia-inducible factor and metabolic pathways: Possible targets of cancer. Cell & Bioscience, 7, 62."}, {"Citation": "Sinha, N., & Dabla, P. K. (2015). Oxidative stress and antioxidants in hypertension-A current review. Current Hypertension Reviews, 11, 132-142."}, {"Citation": "Soda, K. (2011). The mechanisms by which polyamines accelerate tumor spread. Journal of Experimental & Clinical Cancer Research, 30, 95."}, {"Citation": "Soleimani, A., Rahmani, F., Saeedi, N., Ghaffarian, R., Khazaei, M., Ferns, G. A., Avan, A., & Hassanian, S. M. (2019). The potential role of regulatory microRNAs of RAS/MAPK signaling pathway in the pathogenesis of colorectal cancer. Journal of Cellular Biochemistry, 120, 19245-19253."}, {"Citation": "Son, Y., Cheong, Y. K., Kim, N. H., Chung, H. T., Kang, D. G., & Pae, H. O. (2011). Mitogen-activated protein kinases and reactive oxygen species: How can ROS activate MAPK pathways? Journal of Signal Transduction, 2011, 792639-6."}, {"Citation": "Strekalova, E., Malin, D., Weisenhorn, E. M. M., Russell, J. D., Hoelper, D., Jain, A., Coon, J. J., Lewis, P. W., & Cryns, V. L. (2019). S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells. Breast Cancer Research and Treatment, 175, 39-50."}, {"Citation": "Sun, X., Yang, Y., Zhong, X. Z., Cao, Q., Zhu, X. H., Zhu, X., & Dong, X. P. (2018). A negative feedback regulation of MTORC1 activity by the lysosomal Ca(2+) channel MCOLN1 (mucolipin 1) using a CALM (calmodulin)-dependent mechanism. Autophagy, 14, 38-52."}, {"Citation": "Sun, Y., He, W., Luo, M., Zhou, Y., Chang, G., Ren, W., Wu, K., Li, X., Shen, J., Zhao, X., & Hu, Y. (2015). SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism. Tumour Biology, 36, 4133-4141."}, {"Citation": "Tajan, M., Hock, A. K., Blagih, J., Robertson, N. A., Labuschagne, C. F., Kruiswijk, F., Humpton, T. J., Adams, P. D., & Vousden, K. H. (2018). A Role for p53 in the adaptation to glutamine starvation through the expression of SLC1A3. Cell Metabolism, 28, 721-736."}, {"Citation": "Tan, Y., Lin, K., Zhao, Y., Wu, Q., Chen, D., Wang, J., Liang, Y., Li, J., Hu, J., Wang, H., Liu, Y., Zhang, S., He, W., Huang, Q., Hu, X., Yao, Z., Liang, B., Liao, W., & Shi, M. (2018). Adipocytes fuel gastric cancer omental metastasis via PITPNC1-mediated fatty acid metabolic reprogramming. Theranostics, 8, 5452-5468."}, {"Citation": "Taniguchi, T., Iizumi, Y., Watanabe, M., Masuda, M., Morita, M., Aono, Y., Toriyama, S., Oishi, M., Goi, W., & Sakai, T. (2016). Resveratrol directly targets DDX5 resulting in suppression of the mTORC1 pathway in prostate cancer. Cell Death & Disease, 7, e2211."}, {"Citation": "Teng, L., Chen, Y., Cao, Y., Wang, W., Xu, Y., Wang, Y., Lv, J., Li, C., & Su, Y. (2018). Overexpression of ATP citrate lyase in renal cell carcinoma tissues and its effect on the human renal carcinoma cells in vitro. Oncology Letters, 15, 6967-6974."}, {"Citation": "Thyagarajan, A., & Sahu, R. P. (2018). Potential contributions of antioxidants to cancer therapy: Immunomodulation and radiosensitization. Integrative Cancer Therapies, 17, 210-216."}, {"Citation": "Todenh\u00f6fer, T., Seiler, R., Stewart, C., Moskalev, I., Gao, J., Ladhar, S., Kamjabi, A., Al Nakouzi, N., Hayashi, T., Choi, S., Wang, Y., Frees, S., Daugaard, M., Oo, H. Z., Fisel, P., Schwab, M., Schaeffeler, E., Douglas, J., Hennenlotter, J., \u2026 Black, P. C. (2018). Selective inhibition of the lactate transporter MCT4 reduces growth of invasive bladder cancer. Molecular Cancer Therapeutics, 17, 2746-2755."}, {"Citation": "Tong, L., Chuang, C. C., Wu, S., & Zuo, L. (2015). Reactive oxygen species in redox cancer therapy. Cancer Letters, 367, 18-25."}, {"Citation": "Torgovnick, A., & Schumacher, B. (2015). DNA repair mechanisms in cancer development and therapy. Frontiers in Genetics, 6, 157."}, {"Citation": "Trejo-Solis, C., Pedraza-Chaverri, J., Torres-Ramos, M., Jimenez-Farfan, D., Cruz Salgado, A., Serrano-Garcia, N., Osorio-Rico, L., & Sotelo, J. (2013). Multiple molecular and cellular mechanisms of action of lycopene in cancer inhibition. Evidence-based Complementary and Alternative Medicine, 2013, 705121-17."}, {"Citation": "Vaghari-Tabari, M., Moein, S., Qujeq, D., Kashifard, M., & Hajian-Tilaki, K. (2018). Positive correlation of fecal calprotectin with serum antioxidant enzymes in patients with inflammatory bowel disease: Accidental numerical correlation or a new finding? American Journal of the Medical Sciences, 355, 449-455."}, {"Citation": "Varghese, S., Samuel, S. M., Varghese, E., Kubatka, P., & Busselberg, D. (2019). High glucose represses the anti-proliferative and pro-apoptotic effect of metformin in triple negative breast cancer cells. Biomolecules, 9, 9."}, {"Citation": "Voskas, D., Ling, L. S., & Woodgett, J. R. (2010). Does GSK-3 provide a shortcut for PI3K activation of Wnt signalling? F1000 Biology Reports, 2, 82."}, {"Citation": "Wagner, R., St\u00fcbiger, G., Veigel, D., Wuczkowski, M., Lanzerstorfer, P., Weghuber, J., Karteris, E., Nowikovsky, K., Wilfinger-Lutz, N., Singer, C. F., Colomer, R., Benham\u00fa, B., L\u00f3pez-Rodr\u00edguez, M. L., Valent, P., & Grunt, T. W. (2017). Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells. Oncotarget, 8, 11600-11613."}, {"Citation": "Wang, C., Guo, K., Gao, D., Kang, X., Jiang, K., Li, Y., Sun, L., Zhang, S., Sun, C., Liu, X., Wu, W., Yang, P., & Liu, Y. (2011). Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples. Cancer Letters, 313, 154-166."}, {"Citation": "Wang, C., Ma, J., Zhang, N., Yang, Q., Jin, Y., & Wang, Y. (2015). The acetyl-CoA carboxylase enzyme: A target for cancer therapy? Expert Review of Anticancer Therapy, 15, 667-676."}, {"Citation": "Wang, D., Yin, L., Wei, J., Yang, Z., & Jiang, G. (2017). ATP citrate lyase is increased in human breast cancer, depletion of which promotes apoptosis. Tumour Biology, 39, 1010428317698338."}, {"Citation": "Wang, G., Fu, X. L., Wang, J. J., Guan, R., Sun, Y., & Tony To, S. S. (2019). Inhibition of glycolytic metabolism in glioblastoma cells by Pt3glc combined with PI3K inhibitor via SIRT3-mediated mitochondrial and PI3K/Akt-MAPK pathway. Journal of Cellular Physiology, 234, 5888-5903."}, {"Citation": "Wang, L., Chen, Y., Sternberg, P., & Cai, J. (2008). Essential roles of the PI3 kinase/Akt pathway in regulating Nrf2-dependent antioxidant functions in the RPE. Investigative Ophthalmology & Visual Science, 49, 1671-1678."}, {"Citation": "Wang, L., Xiong, H., Wu, F., Zhang, Y., Wang, J., Zhao, L., Guo, X., Chang, L. J., Zhang, Y., You, M. J., Koochekpour, S., Saleem, M., Huang, H., Lu, J., & Deng, Y. (2014). Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth. Cell Reports, 8, 1461-1474."}, {"Citation": "Wang, N., Huo, R., Cai, B., Lu, Y., Ye, B., Li, X., Li, F., & Xu, H. (2016). Activation of Wnt/beta-catenin signaling by hydrogen peroxide transcriptionally inhibits NaV1.5 expression. Free Radical Biology & Medicine, 96, 34-44."}, {"Citation": "Wang, R., Cheng, Y., Su, D., Gong, B., He, X., Zhou, X., Pang, Z., Cheng, L., Chen, Y., & Yao, Z. (2017). Cpt1c regulated by AMPK promotes papillary thyroid carcinomas cells survival under metabolic stress conditions. Journal of Cancer, 8, 3675-3681."}, {"Citation": "Warburg, O., Wind, F., & Negelein, E. (1927). The metabolism of tumors in the body. The Journal of General Physiology, 8, 519-530."}, {"Citation": "Watt, M. J., Clark, A. K., Selth, L. A., Haynes, V. R., Lister, N., Rebello, R., Porter, L. H., Niranjan, B., Whitby, S. T., Lo, J., Huang, C., Schittenhelm, R. B., Anderson, K. E., Furic, L., Wijayaratne, P. R., Matzaris, M., Montgomery, M. K., Papargiris, M., Norden, S., \u2026 Taylor, R. A. (2019). Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer. Science Translational Medicine, 11, 11."}, {"Citation": "Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R., & Chandel, N. S. (2010). Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proceedings of the National Academy of Sciences of the United States of America, 107, 8788-8793."}, {"Citation": "Wen, H., Wu, Z., Hu, H., Wu, Y., Yang, G., Lu, J., Yang, G., Guo, G., & Dong, Q. (2018). The anti-tumor effect of pachymic acid on osteosarcoma cells by inducing PTEN and caspase 3/7-dependent apoptosis. Journal of Natural Medicines, 72, 57-63."}, {"Citation": "Wu, K. L., Wu, C. A., Wu, C. W., Chan, S. H., Chang, A. Y., & Chan, J. Y. (2013). Redox-sensitive oxidation and phosphorylation of PTEN contribute to enhanced activation of PI3K/Akt signaling in rostral ventrolateral medulla and neurogenic hypertension in spontaneously hypertensive rats. Antioxidants & Redox Signaling, 18, 36-50."}, {"Citation": "Xiao, A., Brenneman, B., Floyd, D., Comeau, L., Spurio, K., Olmez, I., Lee, J., Nakano, I., Godlewski, J., Bronisz, A., Kagaya, N., Shin-ya, K., & Purow, B. (2019). Statins affect human glioblastoma and other cancers through TGF-beta inhibition. Oncotarget, 10, 1716-1728."}, {"Citation": "Xu, J., Murphy, S. L., Kochanek, K. D., & Arias, E. (2016). Mortality in the United States, 2015. NCHS Data Brief, 1-8."}, {"Citation": "Xue, Y. N., Yu, B. B., Li, J. L., Guo, R., Zhang, L. C., Sun, L. K., Liu, Y. N., & Li, Y. (2019). Zinc and p53 disrupt mitochondrial binding of HK2 by phosphorylating VDAC1. Experimental Cell Research, 374, 249-258."}, {"Citation": "Yahagi, N., Shimano, H., Matsuzaka, T., Najima, Y., Sekiya, M., Nakagawa, Y., Ide, T., Tomita, S., Okazaki, H., Tamura, Y., Iizuka, Y., Ohashi, K., Gotoda, T., Nagai, R., Kimura, S., Ishibashi, S., Osuga, J., & Yamada, N. (2003). p53 Activation in adipocytes of obese mice. The Journal of Biological Chemistry, 278, 25395-25400."}, {"Citation": "Yan, C., Wei, H., Minjuan, Z., Yan, X., Jingyue, Y., Wenchao, L., & Sheng, H. (2014). The mTOR inhibitor rapamycin synergizes with a fatty acid synthase inhibitor to induce cytotoxicity in ER/HER2-positive breast cancer cells. PLOS One, 9, e97697."}, {"Citation": "Yang, C. M., Ji, S., Li, Y., Fu, L. Y., Jiang, T., & Meng, F. D. (2017). beta-Catenin promotes cell proliferation, migration, and invasion but induces apoptosis in renal cell carcinoma. OncoTargets and Therapy, 10, 711-724."}, {"Citation": "Yao, C. A., Ortiz-Vega, S., Sun, Y. Y., Chien, C. T., Chuang, J. H., & Lin, Y. (2017). Association of mSin1 with mTORC2 Ras and Akt reveals a crucial domain on mSin1 involved in Akt phosphorylation. Oncotarget, 8, 63392-63404."}, {"Citation": "Yao, H., Ashihara, E., & Maekawa, T. (2011). Targeting the Wnt/beta-catenin signaling pathway in human cancers. Expert Opinion on Therapeutic Targets, 15, 873-887."}, {"Citation": "Yecies, J. L., & Manning, B. D. (2011). Transcriptional control of cellular metabolism by mTOR signaling. Cancer Research, 71, 2815-2820."}, {"Citation": "Yi, K. H., & Lauring, J. (2016). Recurrent AKT mutations in human cancers: Functional consequences and effects on drug sensitivity. Oncotarget, 7, 4241-4251."}, {"Citation": "Yoon, C. Y., Shim, Y. J., Kim, E. H., Lee, J. H., Won, N. H., Kim, J. H., Park, I. S., Yoon, D. K., & Min, B. H. (2007). Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase. International Journal of Cancer, 120, 897-905."}, {"Citation": "Yoon, M., Jung, S. J., Kim, T. H., Ha, T. K., Urm, S. H., Park, J. S., Lee, S. M., & Bae, S. K. (2016). Relationships between transporter expression and the status of BRAF V600E mutation and F-18 FDG uptake in papillary thyroid carcinomas. Endocrine Research, 41, 64-69."}, {"Citation": "Yoon, S., Lee, M. Y., Park, S. W., Moon, J. S., Koh, Y. K., Ahn, Y. H., Park, B. W., & Kim, K. S. (2007). Up-regulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells. The Journal of Biological Chemistry, 282, 26122-26131."}, {"Citation": "Young, C. D., & Anderson, S. M. (2009). Rah, rah, ROS: Metabolic changes caused by loss of adhesion induce cell death. Breast Cancer Research, 11, 307."}, {"Citation": "Zaidi, N., Swinnen, J. V., & Smans, K. (2012). ATP-citrate lyase: A key player in cancer metabolism. Cancer Research, 72, 3709-3714."}, {"Citation": "Zaugg, K., Yao, Y., Reilly, P. T., Kannan, K., Kiarash, R., Mason, J., Huang, P., Sawyer, S. K., Fuerth, B., Faubert, B., Kalliomaki, T., Elia, A., Luo, X., Nadeem, V., Bungard, D., Yalavarthi, S., Growney, J. D., Wakeham, A., Moolani, Y., \u2026 Mak, T. W. (2011). Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes & Development, 25, 1041-1051."}, {"Citation": "Zeng, Y. H., Zhou, L. Y., Chen, Q. Z., Li, Y., Shao, Y., Ren, W. Y., Liao, Y. P., Wang, H., Zhu, J. H., Huang, M., He, F., Wang, J., Wu, K., & He, B. C. (2017). Resveratrol inactivates PI3K/Akt signaling through upregulating BMP7 in human colon cancer cells. Oncology Reports, 38, 456-464."}, {"Citation": "Zhang, H., Xu, H. L., Wang, Y. C., Lu, Z. Y., Yu, X. F., & Sui, D. Y. (2018). 20(S)-protopanaxadiol-induced apoptosis in MCF-7 breast cancer cell line through the inhibition of PI3K/AKT/mTOR signaling pathway. International Journal of Molecular Sciences, 19, 19."}, {"Citation": "Zhang, J., Fan, J., Venneti, S., Cross, J. R., Takagi, T., Bhinder, B., Djaballah, H., Kanai, M., Cheng, E. H., Judkins, A. R., Pawel, B., Baggs, J., Cherry, S., Rabinowitz, J. D., & Thompson, C. B. (2014). Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion. Molecular Cell, 56, 205-218."}, {"Citation": "Zhao, M., Sun, J., & Zhao, Z. (2012). Distinct and competitive regulatory patterns of tumor suppressor genes and oncogenes in ovarian cancer. PLOS One, 7, e44175."}, {"Citation": "Zhao, Y., Sun, H., Feng, M., Zhao, J., Zhao, X., Wan, Q., & Cai, D. (2018). Metformin is associated with reduced cell proliferation in human endometrial cancer by inbibiting PI3K/AKT/mTOR signaling. Gynecological Endocrinology, 34, 428-432."}, {"Citation": "Zhe, N., Chen, S., Zhou, Z., Liu, P., Lin, X., Yu, M., Cheng, B., Zhang, Y., & Wang, J. (2016). HIF-1alpha inhibition by 2-methoxyestradiol induces cell death via activation of the mitochondrial apoptotic pathway in acute myeloid leukemia. Cancer Biology & Therapy, 17, 625-634."}, {"Citation": "Zhou, C., Qian, W., Ma, J., Cheng, L., Jiang, Z., Yan, B., Li, J., Duan, W., Sun, L., Cao, J., Wang, F., Wu, E., Wu, Z., Ma, Q., & Li, X. (2019). Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1. Cell Proliferation, 52, e12514."}, {"Citation": "Zhou, Q., Zhan, H., Lin, F., Liu, Y., Yang, K., Gao, Q., Ding, M., Liu, Y., Huang, W., & Cai, Z. (2019). LincRNA-p21 suppresses glutamine catabolism and bladder cancer cell growth through inhibiting glutaminase (GLS) expression. Bioscience Reports, 39(4). BSR20182372."}, {"Citation": "Zhu, K., Liu, Q., Zhou, Y., Tao, C., Zhao, Z., Sun, J., & Xu, H. (2015). Oncogenes and tumor suppressor genes: Comparative genomics and network perspectives. BMC Genomics, 16(Suppl. 7), S8."}, {"Citation": "Zhuo, B., Li, Y., Li, Z., Qin, H., Sun, Q., Zhang, F., Shen, Y., Shi, Y., & Wang, R. (2015). PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma. Biochemical and Biophysical Research Communications, 464, 401-406."}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2020", "Month": "12", "Day": "28"}, {"Year": "2020", "Month": "5", "Day": "10"}, {"Year": "2020", "Month": "12", "Day": "30"}, {"Year": "2021", "Month": "2", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "13", "Hour": "5", "Minute": "54"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33580511", "10.1002/jcp.30276"]}}], "PubmedBookArticle": []}